MedPath

Mechanism of Action of Vichy Catalan Water

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Registration Number
NCT01334840
Lead Sponsor
National Research Council, Spain
Brief Summary

Water consumption is essential to maintain hydration and good health. Sodium-bicarbonated mineral waters are reported to have beneficial digestive and hypocholesterolemic properties. The aim of this study was to investigate the effects of the consumption of a sodium-bicarbonated mineral water (BW) with or without a meal, compared to a low mineral content water as a control water (CW), on postprandial serum triacylglycerols (TAG), cholecystokinin (CCK), and gallbladder volume.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Adult (>18 and <40 years)
  • BMI >18 and <30 kg/m2
Exclusion Criteria
  • Age <18 and > 40 years
  • TAG > 250 mg/dL (2.82 mmol/L)
  • Being a usual consumer of carbonic mineral water
  • Obesity
  • Diabetes
  • Hypertension or digestive, liver and renal disease
  • Biliary obstruction
  • Eating disorders
  • Being under medication that could affect lipid metabolism
  • Consumption of functional foods that could affect lipid metabolism (food containing n-3 fatty acids or phytosterols)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Serum triacylglycerolsPostprandial 120 minutes
Secondary Outcome Measures
NameTimeMethod
AldosteronePostprandial 120 minutes
Serum insulinPostprandial 120 minutes
CholecystokininPostprandial 120 minutes
Gallbladder volumePostprandial 120 minutes
Serum glucosePostprandial time 120 minutes

Trial Locations

Locations (1)

Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)

🇪🇸

Madrid, Spain

Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)
🇪🇸Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.